Millions Take Fish Oil For Brain Health. A Two-year Study Found No Benefit

TL;DR

For listenersOffer from Amazon

Turn your wind-down time into listening time

• Thousands of audiobooks, podcasts and originals
• Listen on your phone, tablet or Echo — also offline
• Cancel anytime

Try Audible free →Free trial for new members

As an affiliate, we earn on qualifying purchases.Hide

In a two-year randomized trial, daily fish oil supplements did not significantly improve memory or other cognitive test results, or prevent shrinkage of the hippocampus, among 365 older adults at elevated Alzheimer’s risk. DHA levels in participants’ cerebrospinal fluid rose, but that increase did not translate into measurable benefits in the outcomes studied.

A two-year clinical trial found that daily fish oil supplements did not significantly improve memory or other measured thinking abilities, or prevent shrinkage in a brain region involved in memory, among 365 adults ages 55 to 80 at elevated risk of Alzheimer’s disease. The study, published in eBioMedicine and reported by ScienceDaily, found that DHA levels in participants’ cerebrospinal fluid rose during supplementation, but that increase did not produce measurable benefits on the outcomes researchers assessed.

Participants were randomly assigned to take either a daily supplement providing 2,000 milligrams of DHA, an omega-3 fatty acid, or a placebo. The trial was double-blind, meaning participants and researchers did not know who received the supplement during the study. All participants rarely ate fish, a major food source of omega-3 fatty acids, and were considered at increased risk of Alzheimer’s disease.

After six months, the average DHA concentration in cerebrospinal fluid had increased by 17% among those taking the supplement. Researchers used the fluid, which surrounds the brain and spinal cord, to check whether DHA was reaching the central nervous system. At the two-year assessment, however, supplement users had no significant advantage over the placebo group on cognitive tests. Brain imaging also showed no prevention of shrinkage in the hippocampus, a region important to memory.

Nearly half of participants, 47%, carried the APOE4 gene variant, which is associated with higher risk of late-onset Alzheimer’s disease. Carrying the variant does not mean a person will develop Alzheimer’s. The supplied study report does not provide detailed results separating outcomes by APOE4 status, so the overall findings should not be treated as proof that every subgroup responded identically.

What the Trial Says About Supplements

The findings challenge the expectation that raising omega-3 levels with a supplement will necessarily protect memory as people age. In this group, DHA reached the central nervous system, yet the trial detected no significant cognitive advantage and no prevention of hippocampal shrinkage over two years. That distinction matters: evidence that a nutrient reaches the brain is not the same as evidence that it improves health outcomes.

Fish oil is widely used, and ScienceDaily’s report says Americans spend more than $1 billion a year on supplements containing omega-3 fatty acids. The trial does not establish that fish oil has no effects in every population, or answer whether it benefits people for other reasons. It does mean the study offers no support for using this DHA supplement as a proven way to prevent Alzheimer’s or protect cognition in adults matching the trial participants.

The results may help readers interpret broad marketing or health claims with care: a biological change measured in a study does not automatically translate into a noticeable or clinically meaningful benefit. The trial tested a particular dose, population, duration and set of outcomes. Its findings are relevant to those conditions, rather than a final answer about every omega-3 source or dietary pattern.

Who Took Part in the Trial

The study enrolled adults ages 55 to 80 who rarely ate fish and were considered at elevated risk of Alzheimer’s disease. Researchers compared daily DHA supplementation with a placebo, then assessed cognition at the start and after two years. The double-blind design was intended to reduce bias in how participants and researchers experienced or evaluated the treatment.

DHA is a component of brain cell membranes and is involved in normal neuronal structure and communication. That biological role helped motivate the trial, but it does not by itself show that taking DHA supplements prevents disease. The researchers measured both whether DHA levels changed in cerebrospinal fluid and whether participants’ test results or hippocampal measurements changed in a beneficial way.

The study’s lead investigator, Hussein Naji Yassine, directs the USC Center for Personalized Brain Health. The findings were published in eBioMedicine. The source report also notes that the research team is investigating whether factors such as diet, age, genetic risk and overall health affect how the brain processes omega-3s.

Questions the Trial Leaves Open

The reported results do not establish whether longer-term use would produce different outcomes, or whether other doses, formulations or groups of people might respond differently. The source report describes no significant overall advantage on the measured tests and no protection against hippocampal shrinkage; it does not provide enough detail to assess every possible subgroup or outcome.

It is also unclear from the available report whether omega-3s consumed as part of food have the same effects as an isolated supplement. The researchers are examining how the brain absorbs and uses these fats, and whether factors including dietary pattern, health, age and genetic risk influence that process. The study does not show that fish consumption or a Mediterranean-style diet prevents Alzheimer’s; those questions are distinct from the supplement trial.

The findings should not be read as a personal recommendation to start or stop a supplement. The trial focused on a defined group at elevated risk, and its results do not substitute for individualized advice from a qualified health professional.

Researchers Examine Diet and DHA Use

The USC research team is investigating why higher DHA levels in cerebrospinal fluid did not correspond to better measured cognition or less hippocampal shrinkage. According to the report, the researchers are studying how the brain absorbs, processes and uses omega-3s, and whether health, age, genetic risk and dietary pattern help explain differences.

The investigators have raised the possibility that omega-3s may act differently when consumed within a broader dietary pattern, such as a Mediterranean-style diet that includes fish, vegetables, fruit, whole grains, legumes, nuts and olive oil. That possibility remains an area of inquiry, not a result demonstrated by this two-year supplement trial. Further research will be needed to test whether diet or particular participant characteristics change the outcomes.

Key Questions

Did fish oil improve memory in this study?

No significant improvement was found on cognitive tests after two years among participants taking daily DHA compared with those taking a placebo.

Did the supplement reach participants’ brains?

The study measured DHA in cerebrospinal fluid. After six months, levels had risen by an average of 17% in the supplement group, indicating DHA reached the central nervous system. The increase did not translate into a measurable cognitive benefit in the reported results.

Did fish oil prevent brain shrinkage?

No. Brain imaging showed that the supplements did not prevent shrinkage of the hippocampus, a region involved in forming and organizing memories.

Does this prove omega-3s from food have no benefit?

No. The trial tested a daily DHA supplement in older adults who rarely ate fish. It did not compare fish or a broader diet with the supplement, and the researchers say they are investigating how dietary patterns may affect the brain’s use of omega-3s.

Should people stop taking fish oil?

The study does not provide individual medical advice or answer every reason someone might take fish oil. Anyone considering a change to supplements should discuss it with a qualified health professional.

Source: rss